chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On February 29 in the evening, about 8 days after the shot, the site was very itchy and had a rash.  I used an antihistamine and ice and it improved but in the early morning hours of February 2, I was up with abdominal and gastric discomfort and could not sleep.  I was in bed all the next day with terrible unrelenting headache and fever over 102 degrees.  It began to improve by the evening and upon waking on February 3, I felt better and completely fine by mid-morning.  I went to get a COVID test on Feb. 2 and it came back on Feb. 3 NEGATIVE.  It was a very intense and unpleasant experience and I thought you should know about it and the fact it happened about 10 days after the first Moderna shot.  thank you.
None stated. 11/4/08-records received for DOS 10-18-10/19/08-DC DX: Allergic reaction to influenza shot. After receiving flu shot C/O throat swelling and tingling sensation and numbness in face. Tongue swelling and pressure in chest. Treated in ED and admitted.
As soon as I received my shot I went home, I started to feel fatigue. Most of my symptoms were awful from my lupus. I was not feeling well. I tested my blood sugar and it was 140, I took my metformin. The next couple days the sugar was all over the place. I told my doctor and they did not believe this was a symptom of the vaccine. My first and second vaccine my sugar was going down extremely low like in the 40's.
3:17 PM-DIZZNESS AND NAUSEA AFER GETTING VACCINE. PATIENT WAS GIVEN WATER AND GATORADE.  BP:120/72 PR:65
PATIENT RECEIVED VACCINE. WAS WAITING IN THE LOBBY FOR THE REQUIRED 15 MINUTES WHEN HE STARTED TO LOOK REALLY PALE.  PATIENT LOST CONSCIOUSNESS AND TWO EMPLOYEES AND HIS WIFE LOWERED HIM TO THE GROUND SAFELY.  ANOTHER EMPLOYEE CALLED 911.  PATIENT HAD A PULSE AND WAS BREATHING, ALTHOUGH BREATHS SEEMED IRREGULAR. EMTS ARRIVED AND TOOK HIS VITALS. AT THIS POINT PATIENT HAD REGAINED CONSCIOUSNESS AND WAS RESPONSIVE.  THEY SAT PATIENT UP AND HE FAINTED AGAIN.  THEY TOOK PATIENT TO THE HOSPITAL FOR EVALUATION.  I ASKED WIFE TO CALL ME WITH AN UPDATE AFTER THEY KNOW MORE.
Three days after injection admitted to Hospital, with chest pain radiating to throat and jaw. Pain was "squeezing" sensation. Mild increase in triponon level 24 hours after admission that quickly resolved. Released after 40 hours. Was advised by physician that EKG and echo were normal. Following up with primary. Believe I experienced mild pericardial inflammation. Had a mild heart attack in 2017.  Physician recommended returning to clopidigrel/baby aspirin  and metopralol therapy.
Information has been received from a nurse concerning a 40 and 3/4 week old patient with no medical history or allergies who on 11-OCT-2007, 11-Feb-2008 and 23-May-2008 was vaccinated with the first, second and third doses respectively of ROTATEQ. There was no concomitant medication. No adverse symptoms were reported. Additional information has been requested.
marked redness, pruritus and swelling in the injected arm that looks very much like cellulitis/erysipelas.  Axillary lymph nodes  swell / quite painful.
rash/ rash on eyeborw, shoulder, elbows, arm, stomach, chin, cheek; allergic reaction; tired; itches; This case was reported by a consumer via call center representative and described the occurrence of red rash in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included flu vaccine (received yearly with no reactions. ). Concomitant products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season).   On 22nd October 2019, the patient received the 1st dose of Shingrix. On 3rd November 2019, 12 days after receiving Shingrix, the patient experienced red rash and allergic reaction. In November 2019, the patient experienced pruritus and tiredness. The patient was treated with hydrocortisone (Cortisone Cream (Hydrocortisone)). On an unknown date, the outcome of the red rash was not recovered/not resolved and the outcome of the pruritus was recovered/resolved and the outcome of the allergic reaction and tiredness were unknown.   It was unknown if the reporter considered the red rash, pruritus, allergic reaction and tiredness to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The parteint received Shingrix in left arm and received Flu vaccine in right arm. The patient also received the flu shot (unknown name) on her right arm on the same day, however, she was not relating the flu shot to her rash because she gets the flu vaccine yearly with no reactions. The patient reported that four days before reporting she started to see a little rash above her right eyebrow and one on her left shoulder that then spread to her elbows on both arms on the crease of the inside of her arm. Then the rash started on her stomach near her belly button and the side of her right cheek and under her chin from the ear to her chin area on her left side. The patient described the areas as patches of red rash that itches. The biggest rash area in on her left shoulder and over her right eyebrow. The patient had been putting 0.5 cortisone cream on the rash and it takes the itch away within 30 minutes.  The patient reported that the area where the rash initially started was not bothering her as bad, however, it was still there as new areas arise. All the rash areas continue to be unresolved and she believed that it was an allergic reaction to the Shingrix vaccine. The reporter requesting consent to follow up. In the XML document outcome of rash was reported as recovering, but in Argus its mentioned as not recovered, so kept as reported in Argus.
3rd dose administered; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB35AA, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Bexsero (1st dose received on 30th November 2021) and Bexsero (2nd dose received on 2nd February 2022).   On 5th May 2022, the patient received the 3rd dose of Bexsero and Bexsero Pre-Filled Syringe Device. On 5th May 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 05-MAY-2022 Reporter's comment: The registered nurse reports patient received extra dose of Bexsero.  The reporter consented to follow up.
no adverse effects; a patient received a dose of MMRII via the intramuscular route; This spontaneous report was received from a pharmacist and refers to a patient of an unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 18-OCT-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHa) (M-M-R II), lot # S012944, expiration date 28-APR-2021, for prophylaxis, via intramuscular route (incorrect route of product administration). There were no adverse effects reported. The outcome of incorrect route of product administration and no adverse event was unknown.
Fever (103), projectile vomiting, diarrhea, rash on back, increased heart rate, excessive crying. Went to ER 10/01/2009 at 02:00.
Pt received Pfizer COVID-19 vaccine. Approximately 8 minutes after administration, pt alerted me to feeling hot with mild chest tightness. She stated she has anxiety and was anxious about receiving vaccine. She confirmed no swelling of the tongue, no SOB, no itching or other signs of anaphylaxis. Pt given diphenhydramine x2 and famotidine x1 along with a cup of water. Pt requested O2 and BP be monitored. O2 sat never below 97, BP was high initially at 153/112. Pt also had jacket on initially. Pt advised to breath and relax. Pt reassessed after 10 minutes. Removed jacket for BP check which had come down to 132/94 which pt states is baseline for her as she does have a bit of high BP. She also reported at that time feeling better and had calmed down. She stated she really felt it was anxiety. She left with instructions to call 911 or seek emergency attention if Sx reoccur.
3PM had fever of 103; given APAP; temp @ 6PM 105; given APAP; cried for 2 hrs straight; around 8PM temp still 105; pt taken to ER; given Pediaporfin & APAP suppository; t101;
BRAIN FOG; MAJOR FATIGUE; ENERGY LEVEL NOT AT THE SAME LEVEL IT USED TO BE; This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: penicillin allergy, alcohol user, and non smoker, and other pre-existing medical conditions included: The patient did not have any history of drug abuse or illicit drug use. The patient experienced severe chills and shakes when treated with influenza vaccine for prophylactic vaccination.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 17-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 18-APR-2021, the patient experienced brain fog. On 18-APR-2021, the patient experienced major fatigue. On 18-APR-2021, the patient experienced energy level not at the same level it used to be. Laboratory data (dates unspecified) included: Blood test (NR: not provided) Everything good, and Physical examination (NR: not provided) Not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from brain fog on JUN-2021, was recovering from major fatigue, and had not recovered from energy level not at the same level it used to be. This report was non-serious.
Blurred peripheral vision right (dominant) eye. Extreme dryness. Pain in eye. Extreme light sensitivity. No problem left eye.  No prior problem, had perfect vision my whole life. Eye doctor had me in for two complete check ups to try to determine problem. Had MRI of brain, no problems detected. Had Neurologist check up, no problems detected. Had blood allergy test, no problems. Problem got better with time, six months later had booster shot with immediate same reaction that is still going on today. Booster shot same, 10-23-2021
-pericarditis starting at same night of vaccine -visual hallucinations starting 3 days later
Major chills and mild fever, pain at injection site, swelling lymph nodes, inability to sleep
Felt dizzy and paralyzed. It lasted a couple of minutes. Two days later had an episode that appeared like a seizure. Taken by ambulance and admitted to hospital.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patients received SHINGRIX. On an unknown date, less than a day after receiving SHINGRIX, the patients experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follow: The age at vaccination was not reported. The reporter stated, her provider stated that, the SHINGRIX vaccines were making the patient's arm too sore. This case has been linked to the US2018118657, reported by the same reporter.
Intermittent tingling sensation in lips. Happens multiple times per day. Similar to pins and needles.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Apr2021 09:00 (Lot number: Ew0170) at the age of 32 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VITAMIN D 2000; VITAMIN B12 & FOLIC ACID. Vaccination history included: Bnt162b2 (Dose 1, single , lot number: Er8729,, administration Time: 09:00 AM,, vaccine location: Left arm), administration date: 06Apr2021, when the patient was 32 years old, for Covid-19 immunization. The following information was reported: PARAESTHESIA ORAL (non-serious) with onset 01May2021, outcome "not recovered", described as "Intermittent tingling sensation in lips. Happens multiple times per day. Similar to pins and needles.". Therapeutic measures were not taken as a result of paraesthesia oral.  Additional information: No known allergies, other medical history. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
I had horrible body aches that went away after around 36 hours. Since getting the booster, I have had terrible hypersensitivity to touch all over but really bad on my back. It feels very uncomfortable for anything to touch me.
Day 8 post vaccination noticed red, itchy, warm area (approximately 2.0 inch diameter) on left upper arm in the area where I received vaccine injection. Area was slightly sensitive to touch. The symptoms remained for about 2 days afterwhich the symptoms slowly subsided. By Day 12 post injection, the symptoms had resolved.  Also had sore arm for a few days sarting the afternoon of the injection in the same arm where I received the injection.
2/4/21: First Moderna - left arm.  Sore arm.  5 to 8 days later, rash on arm, under forearm, hand area.  20 days later, rash on chest and neck. 3/4/21: Second Moderna- right arm.  Sore arm, body aches, chills.                   3/5/21:  fainting (2), dizziness, fatigue, diarrhea, body aches.  Stayed in bed.  Drank liquids, ate crackers and rice.                                       Low blood pressure:  103/57; pulse 48.                   3/6/21 - 3/7/21:  Fatigue; low blood pressure:  114/63; 60.  100/61; 82.  106/65; 71.  110/64; 59.  Slept 11 to 12 hrs.                      3/7/21 - 3/8/21:  Basically back to normal.  BP normal  avg 118/78; 75.
Got shot around 4:30 at 5 pm c/o H.A./dull and took 3 (200 mg) ibuprofen. Relief for H.A. Around 7 pm area around shot became itchy - scratched it. Tingly with radiation down to elbow. Feels hot inside. Tingly with movement down to elbow. Rx: Ice BP 148/68. Nursing supervisor to bring to ER to evaluate.
Started with itchy rash on medial right clavicle. The next day rash traveled lateral to lateral right shoulder. Every day rash got worse. Today is one week and reaction is still itchy and sore covering most of my right shoulder with a few spots going down right arm. I also received the Johnson and Johnson vaccine on 9/13/21
pt recvd vax on 1OCT93 & exp soreness on 3OCT93 inc soreness in lt deltoid on 4OCt93; orange size redden raised area w/soreness noted; ice & cool cloth being applied;
The first day, 3/31, I had severe joint and body aches, chills with a fever. I had a very bad headache in the temple area that last 24 hours. Day 2, I had bad sinus congestion that felt like a bad head cold that lasted 24 hours. Yesterday, 4/2, it turned into a very sore throat that lasted all through the night. When I woke up this morning, 4/3, the pain has subsided, and I was able to talk. As of now, no new symptoms have come about.
URTICARIA treated with Benadryl and topical hydrocortisone Patient seen in office 9/7, symptoms started 9/2. Diffuse rash. Improved with treatment.
Red rash ocurred. Visiting nurse outlined with a pen and it grew larger the next day.
Transient Global Amnesia on  3/14/21:  when my husband got up I was already up. i was asking questions about where things were that I should have known.  I came back to myself and was then ok,  Because I was concerned by the strangeness of the incident i went to my  doctor the next day.  He sent me for tests and told me to follow up with cardiologist. which i did. t
11 adult patients received the expired Bivalent booster beyond 30 days; No adverse event; 11 adult patients received the expired Bivalent booster beyond 30 days; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (11 adult patients received the expired Bivalent booster beyond 30 days), PRODUCT STORAGE ERROR (11 adult patients received the expired Bivalent booster beyond 30 days) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 042H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    In January 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In January 2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (11 adult patients received the expired Bivalent booster beyond 30 days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (11 adult patients received the expired Bivalent booster beyond 30 days) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (11 adult patients received the expired Bivalent booster beyond 30 days), PRODUCT STORAGE ERROR (11 adult patients received the expired Bivalent booster beyond 30 days) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (11 adult patients received the expired Bivalent booster beyond 30 days) and PRODUCT STORAGE ERROR (11 adult patients received the expired Bivalent booster beyond 30 days).    This case contains information for the 10th out of 11 adult patients described by the reporter. No concomitant information was reported. 11 adult patients received the expired Bivalent booster beyond 30 days in the refrigerator. At this time reporter does not have the patient information handy and reporter was not sure if any of those patients received any other vaccines at the same time. Vaccine vials were a case of 10pcs and 7 vials from the case were used to administer vaccines from 13JAN2023 thru 22JAN2023. Reporter advised that 11 doses of vaccines were used from the 7 vials. Reporter advised that label on case of vials advised that vials should have been used before 12JAN2023 Reporter advised that NONE of the patients that have received the 11 doses have reported any adverse reactions. it was intact cartons, 2.5 ml, The vial was initially stored in the refrigerator 13DEC2022 and administration of vaccine from 13JAN2023 thru 22JAN2023. Vial did not undergo any temperature excursions. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704253 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704253:Master case  1st adult patient
1ST TIME - INJ 1/6/21 EL0142 (throbbing headache after I left the hospital. It didn't go away until I took 2 Exedrin & went to bed. I also had some nausea as well and was fatigued).  2ND VACCINE - INJ 1/29/21 EL324 (much worse - fatigue, muscle pain, extreme nausea, headache, and metallic taste in mouth after 15 min wait passed. i also had an inj site reaction. my right arm was burning and i had a stinging pain)
cough; headache; feeling sick; This is a spontaneous report from a Pfizer-sponsored program Covax US Support. A contactable consumer reported for male patient of an unspecified age (Father) that he received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration on 05Mar2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced cough, headache, feeling sick on an unspecified date. His second dose was scheduled on 26Mar2021. Reporter asked if it was okay to get the second dose. The outcome of event was unknown.  Follow up attempts are Completed. No further information is expected.
Information has been received from a physician concerning a healthy 9 week old haemophilus b conjugate vaccine + hepatitis b vaccine recombinant (yeast) )+(o.5ml) (lot 631661/1291J). Concomitant vaccinations on 2/7/00 included 1 dose, SC, in the right thigh, of poliovirus vaccine inactivated (IPOL) (lot P0823) (0.5ml) and 1 dose, IM, in the left thigh of diphtheria toxoid/pertussis vaccine/tetanus (lot 4676741) (0.5ml). It was also noted that on 2/7/00, the pt received 1 dose, in the left thigh, of hepatitis b vaccine recombinant (yeast) (MSD) (lot 633506/1527J) (0.5ml). On 2/10/00, the pt experienced angioedema affecting all 4 extremities, fever, irritability and soreness. The pt recovered after 2 weeks of steroids. The pt had similar experience following exposure to MMRII (MSD) (WAES 01050238). Upon internal review, the pt's experiences were considered to be "Other Medical Events". Additional information has been requested.
Left facial droop, watery eyes.  Not able to close left eye.  P: Prednisone 20 mg twice a day for 10 days. Lubricating eye drops Sent to ER for CT and blood work:  Both WNL P: add Ergocalciferol 50,000=1.25
Moderna 2nd dose given too early.  First dose was on 6/21/21 and second dose was given 7/6/21.